Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance ...

CVS Health (NYSE:CVS) is scheduled to announce Q4 earnings results on Wednesday, February 12th, before market open. Analysts expect a profit of $0.92 (-56.6% Y/Y) on revenue of $96.88B (+3.3% Y/Y).

Edward Jones last night upgraded CVS Health (CVS) to Buy from Hold. The company could be an attractive turnaround story” with the potential for ...

CVS Health (NYSE:CVS – Get Free Report) is projected to release its earnings data before the market opens on Wednesday, ...

Edward Jones upgraded CVS Health (CVS) to Buy from Hold.Invest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover their ...

NYSE CVS opened at $56.53 on Thursday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health has a fifty-two week low of $43.56 and a fifty ...

Benchmark upgraded Meta Platforms (META) to Buy from Hold with a $820 price target, citing a "strong" 2025 core business ...

On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently ...

Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. The investment firm said it believes CVS (NYSE:CVS) will improve ...

On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, ...